Magnetic Resonance Elastography
Motion-sensitive MRI shear wave mapping — the most accurate noninvasive imaging modality for staging hepatic fibrosis in MASH.
MRE is widely considered the gold-standard noninvasive scan for staging liver scarring, especially when blood tests and FibroScan disagree or when higher body weight makes ultrasound unreliable. During the scan, a small plastic disc rests over your right ribs and hums gently while the MRI maps stiffness across a huge cross-section of your liver. Watch the scale carefully when reading your report: MRE kPa numbers are about one-third the size of FibroScan kPa numbers (for example, 3.62 kPa on MRE already points to advanced F3 fibrosis, whereas 3.6 kPa on a FibroScan would be completely normal!).
What Is MRE?
- MRE measures liver stiffness using specialized equipment and programs in conjunction with standard MRI systems1,2
How Is It Performed?
- Patients should fast for 3–4 hours before the exam to avoid fibrosis over-staging due to postprandial liver stiffness3
- Regulatory-approved MRE systems from major MRI manufacturers use standardized processing to generate liver stiffness maps4
- Shear waves are generated by the active driver and travel to the passive driver through a flexible connecting tube; tissue response is captured using motion-sensitive MRI sequences1,4
Use in MASLD/MASH Care
- MRE is considered to be the most accurate noninvasive imaging technique for staging liver fibrosis in MASH6
- Typically used as a second-line test after first-line blood testing (eg, FIB-4), when other test results are inconclusive, or if there is clinical suspicion of more advanced disease2,6
Strengths
- High diagnostic accuracy in detecting fibrosis stage ≥F26
- Can be used to assess fibrosis regression, progression, or stability7
- LSM by MRE can predict future LREs or outcomes in patients with MASLD8,c
Limitations
- MRE requires specialized hardware and software, limiting availability in some MRI-equipped centers2
- Although MRE can be useful in patients with Class III obesity when TE or ARFI-SWE is inconclusive, its performance may be limited by body habitus9,10
- Hepatic iron overload can interfere with diagnosis using MRE11
Published Cutoff Values for Fibrosis Staging Using MRE5
| Parameter | Cutoff, kPa | Sensitivity,a % | Specificity,b % |
|---|---|---|---|
| ≥F2 | 2.97 | 84.9 | 85.4 |
| ≥F3 | 3.62 | 82.5 | 83.2 |
| F4 | 4.7 | 80.0 | 85.9 |